Recent advances in immunotherapy and monoclonal antibody treatment of cancer

Jonathan D. Cheng; Paula T. Rieger; Margaret von Mehren; Gregory P. Adams; Louis M. Weiner

doi:10.1053/sonu.2000.19775

Recent advances in immunotherapy and monoclonal antibody treatment of cancer

Jonathan D. Cheng, Paula T. Rieger, Margaret von Mehren, Gregory P. Adams, Louis M. Weiner

Research output: Contribution to journal › Article › peer-review

17 Scopus citations

Abstract

OBJECTIVES: To review the immune response and tumor immunology, and to provide an update on the success and obstacles to targeted therapy using monoclonal antibodies and antibody conjugates. DATA SOURCES: Research articles and textbooks. CONCLUSIONS: Ongoing studies are exploiting the targeting properties of the immune system to improve anticancer therapy. Both monoclonal antibodies and immunoconjugates have shown promise in treatment of specific diseases. IMPLICATIONS FOR NURSING PRACTICE: The rapid growth of molecular techniques has allowed for the development of new anticancer therapies. Since nurses are intimately involved in the delivery of such therapy as well as in educating patients regarding risks and benefits, they must be knowledgeable.

Original language	English
Pages (from-to)	2-12
Number of pages	11
Journal	Seminars in Oncology Nursing
Volume	16
Issue number	4
DOIs	https://doi.org/10.1053/sonu.2000.19775
State	Published - Nov 2000

Keywords

Antibodies, Monoclonal/therapeutic use
Humans
Immunotherapy
Neoplasm Metastasis
Neoplasms/nursing
Oncology Nursing

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1053/sonu.2000.19775

Cite this

@article{7eb9366cd68844b18421e4cc91a33c90,

title = "Recent advances in immunotherapy and monoclonal antibody treatment of cancer",

abstract = "OBJECTIVES: To review the immune response and tumor immunology, and to provide an update on the success and obstacles to targeted therapy using monoclonal antibodies and antibody conjugates. DATA SOURCES: Research articles and textbooks. CONCLUSIONS: Ongoing studies are exploiting the targeting properties of the immune system to improve anticancer therapy. Both monoclonal antibodies and immunoconjugates have shown promise in treatment of specific diseases. IMPLICATIONS FOR NURSING PRACTICE: The rapid growth of molecular techniques has allowed for the development of new anticancer therapies. Since nurses are intimately involved in the delivery of such therapy as well as in educating patients regarding risks and benefits, they must be knowledgeable.",

keywords = "Antibodies, Monoclonal/therapeutic use, Humans, Immunotherapy, Neoplasm Metastasis, Neoplasms/nursing, Oncology Nursing",

author = "Cheng, {Jonathan D.} and Rieger, {Paula T.} and {von Mehren}, Margaret and Adams, {Gregory P.} and Weiner, {Louis M.}",

year = "2000",

month = nov,

doi = "10.1053/sonu.2000.19775",

language = "English",

volume = "16",

pages = "2--12",

journal = "Seminars in Oncology Nursing",

issn = "0749-2081",

publisher = "W.B. Saunders Ltd",

number = "4",

}

TY - JOUR

T1 - Recent advances in immunotherapy and monoclonal antibody treatment of cancer

AU - Cheng, Jonathan D.

AU - Rieger, Paula T.

AU - von Mehren, Margaret

AU - Adams, Gregory P.

AU - Weiner, Louis M.

PY - 2000/11

Y1 - 2000/11

N2 - OBJECTIVES: To review the immune response and tumor immunology, and to provide an update on the success and obstacles to targeted therapy using monoclonal antibodies and antibody conjugates. DATA SOURCES: Research articles and textbooks. CONCLUSIONS: Ongoing studies are exploiting the targeting properties of the immune system to improve anticancer therapy. Both monoclonal antibodies and immunoconjugates have shown promise in treatment of specific diseases. IMPLICATIONS FOR NURSING PRACTICE: The rapid growth of molecular techniques has allowed for the development of new anticancer therapies. Since nurses are intimately involved in the delivery of such therapy as well as in educating patients regarding risks and benefits, they must be knowledgeable.

AB - OBJECTIVES: To review the immune response and tumor immunology, and to provide an update on the success and obstacles to targeted therapy using monoclonal antibodies and antibody conjugates. DATA SOURCES: Research articles and textbooks. CONCLUSIONS: Ongoing studies are exploiting the targeting properties of the immune system to improve anticancer therapy. Both monoclonal antibodies and immunoconjugates have shown promise in treatment of specific diseases. IMPLICATIONS FOR NURSING PRACTICE: The rapid growth of molecular techniques has allowed for the development of new anticancer therapies. Since nurses are intimately involved in the delivery of such therapy as well as in educating patients regarding risks and benefits, they must be knowledgeable.

KW - Antibodies, Monoclonal/therapeutic use

KW - Humans

KW - Immunotherapy

KW - Neoplasm Metastasis

KW - Neoplasms/nursing

KW - Oncology Nursing

UR - http://www.scopus.com/inward/record.url?scp=0034327244&partnerID=8YFLogxK

U2 - 10.1053/sonu.2000.19775

DO - 10.1053/sonu.2000.19775

M3 - Article

C2 - 11151455

AN - SCOPUS:0034327244

SN - 0749-2081

VL - 16

SP - 2

EP - 12

JO - Seminars in Oncology Nursing

JF - Seminars in Oncology Nursing

IS - 4

ER -

Recent advances in immunotherapy and monoclonal antibody treatment of cancer

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this